These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9181761)

  • 21. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V; Mammarella A; Alessandrini A; Barlattani M
    Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
    D'Eri A; Martini R; Cordova RM; Trevisan G; Andreozzi GM
    Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dialysis clearance of buflomedil in hemodialysed patients.
    Rey E; Moynot A; d'Athis P; Pello JY; Maurel A; Frydman MO; Buisson C; Olive G
    Arzneimittelforschung; 1996 May; 46(5):492-5. PubMed ID: 8737633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease].
    Lemke R; Klaus D
    Vasa; 1984; 13(2):171-4. PubMed ID: 6741240
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
    Di Salvo MM; Ardita G; Giani L; Mugno F; Stevenazzi F; Mazzone A
    Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G; Baldoni F; Peruzzi G; Raimondi G; Grimaldi I; Visigalli G; Gristina S; Massaro M; De Martinis L; Sangiorgi M
    Cardiologia; 1983 Aug; 28(8):651-60. PubMed ID: 6687209
    [No Abstract]   [Full Text] [Related]  

  • 27. [MR-Imaging of lower leg muscle perfusion].
    Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
    Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L; Gandolfo AM; Utz C
    MMW Munch Med Wochenschr; 1984 Mar; 126(9):247-8. PubMed ID: 6425678
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J; Intaglietta M; Messmer K
    Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Scintigraphy with thallium-201 in the evaluation of vasoactive treatment in subjects with obliterative arteriopathies of the lower limbs].
    Licata G; Parrinello G; Scaglione R; Indovina A; Pinto A; Capuana G; Mazzola G
    Cardiologia; 1987 Nov; 32(11):1449-56. PubMed ID: 2965976
    [No Abstract]   [Full Text] [Related]  

  • 31. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P; Pagratis N
    Angiology; 1981 Oct; 32(10):679-85. PubMed ID: 7325404
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.
    Allegra C; Antignani PL; Schachter I; Koverech A; Messano M; Virmani A
    Ann Vasc Surg; 2008; 22(4):552-8. PubMed ID: 18502605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation?
    Wysokinski WE; Spittell PC; Pellikka PA; Miller WL; Seward JB
    Int Angiol; 1998 Sep; 17(3):201-7. PubMed ID: 9821035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analgesic effects of adenosine in syndrome X are counteracted by theophylline: a double-blind placebo-controlled study.
    Eriksson BE; Sadigh B; Svedenhag J; Sylvén C
    Clin Sci (Lond); 2000 Jan; 98(1):15-20. PubMed ID: 10600654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
    Dal Lago A; De Martini D; Flore R; Gaetani E; Gasbarrini A; Gerardino L; Pola R; Santoliquido A; Serricchio M; Tondi P; Nolfe G
    Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication, and its improvement after supervised physical training.
    Andreozzi GM; Leone A; Laudani R; Deinite G; Martini R
    Int Angiol; 2007 Mar; 26(1):12-7. PubMed ID: 17353883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution].
    Visconti W; Grillo N
    Minerva Med; 1985 May; 76(19-20):945-53. PubMed ID: 3158842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surheme in chronic obliterative arteriopathies of the lower limbs].
    Desruelles J; Waucampt JJ
    Lille Med; 1971 Jan; 16():Suppl 1:224-9. PubMed ID: 5162043
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV.
    Briguglio F; Briguglio E; Di Marco V; Swat M; Materia G; Intilisano A
    J Int Med Res; 1986; 14(3):115-23. PubMed ID: 3721052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.